BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11315190)

  • 1. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists.
    Abdel-Malek ZA
    Cell Mol Life Sci; 2001 Mar; 58(3):434-41. PubMed ID: 11315190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.
    Starowicz K; Przewłocka B
    Life Sci; 2003 Jul; 73(7):823-47. PubMed ID: 12798410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the physiological functions of the melanocortin system.
    Cone RD
    Endocr Rev; 2006 Dec; 27(7):736-49. PubMed ID: 17077189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects on the melanocortins and their receptors.
    Wikberg JE; Muceniece R; Mandrika I; Prusis P; Lindblom J; Post C; Skottner A
    Pharmacol Res; 2000 Nov; 42(5):393-420. PubMed ID: 11023702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin Receptors: Emerging Targets for the Treatment of Pigmentation, Inflammation, Stress, Weight Disorders and Sexual Dysfunction.
    Maurya MR; Munshi R; Zambare S
    Curr Drug Targets; 2023; 24(2):151-156. PubMed ID: 36366845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
    MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
    Eur J Pharmacol; 2002 Aug; 450(1):93-109. PubMed ID: 12176114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
    MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
    Eur J Pharmacol; 2002 Apr; 440(2-3):141-57. PubMed ID: 12007532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melanocortin system.
    Gantz I; Fong TM
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E468-74. PubMed ID: 12556347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, diabetes and functions for proopiomelanocortin-derived peptides.
    Mountjoy KG; Wong J
    Mol Cell Endocrinol; 1997 Apr; 128(1-2):171-7. PubMed ID: 9140088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortin receptors and antagonists regulate pigmentation and body weight.
    Jordan SA; Jackson IJ
    Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic melanocortin receptor agonists and antagonists.
    Lerner MR
    Ann N Y Acad Sci; 1999 Oct; 885():153-60. PubMed ID: 10816648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central melanocortin signaling in eating disorders.
    Lu XY
    Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant agouti-signaling protein on melanocortin action.
    Yang YK; Ollmann MM; Wilson BD; Dickinson C; Yamada T; Barsh GS; Gantz I
    Mol Endocrinol; 1997 Mar; 11(3):274-80. PubMed ID: 9058374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into G-protein-coupled receptor signaling from the melanocortin receptor system.
    Rana BK
    Mol Pharmacol; 2003 Jul; 64(1):1-4. PubMed ID: 12815154
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanocortins and reproduction.
    Schiöth HB; Watanobe H
    Brain Res Brain Res Rev; 2002 Feb; 38(3):340-50. PubMed ID: 11890981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New ligands for melanocortin receptors.
    Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin receptor binding determinants in the agouti protein.
    Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
    Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands.
    van der Kraan M; Adan RA; Entwistle ML; Gispen WH; Burbach JP; Tatro JB
    Endocrinology; 1998 May; 139(5):2348-55. PubMed ID: 9564844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of endogenous and synthetic melanocortin peptides.
    Wilson KR; Todorovic A; Proneth B; Haskell-Luevano C
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):3-20. PubMed ID: 16914082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.